HUT77385A - Ibuprofent és kodeint tartalmazó, tökéletesített gyógyászati készítmények - Google Patents

Ibuprofent és kodeint tartalmazó, tökéletesített gyógyászati készítmények

Info

Publication number
HUT77385A
HUT77385A HU9701774A HU9701774A HUT77385A HU T77385 A HUT77385 A HU T77385A HU 9701774 A HU9701774 A HU 9701774A HU 9701774 A HU9701774 A HU 9701774A HU T77385 A HUT77385 A HU T77385A
Authority
HU
Hungary
Prior art keywords
codeine
pharmaceutical formulations
formulations containing
improved pharmaceutical
containing ibuprofen
Prior art date
Application number
HU9701774A
Other languages
English (en)
Other versions
HU227759B1 (en
Inventor
Brian Holmes
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9417041A external-priority patent/GB9417041D0/en
Priority claimed from GB9419921A external-priority patent/GB9419921D0/en
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of HUT77385A publication Critical patent/HUT77385A/hu
Publication of HU227759B1 publication Critical patent/HU227759B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HU9701774A 1994-08-23 1995-08-16 Improved pharmaceutical formulations containing ibuprofen and codeine HU227759B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9417041A GB9417041D0 (en) 1994-08-23 1994-08-23 Improved formulations
GB9419921A GB9419921D0 (en) 1994-10-04 1994-10-04 Improved formulations
PCT/GB1995/001947 WO1996005834A1 (en) 1994-08-23 1995-08-16 Improved pharmaceutical formulations containing ibuprofen and codeine

Publications (2)

Publication Number Publication Date
HUT77385A true HUT77385A (hu) 1998-04-28
HU227759B1 HU227759B1 (en) 2012-02-28

Family

ID=26305507

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9701774A HU227759B1 (en) 1994-08-23 1995-08-16 Improved pharmaceutical formulations containing ibuprofen and codeine

Country Status (24)

Country Link
EP (1) EP0777477B1 (hu)
JP (1) JP3874793B2 (hu)
KR (1) KR100397082B1 (hu)
CN (1) CN1083265C (hu)
AT (1) ATE227574T1 (hu)
AU (1) AU699224B2 (hu)
BG (1) BG63329B1 (hu)
BR (1) BR9508760A (hu)
CA (1) CA2156768A1 (hu)
CZ (1) CZ287558B6 (hu)
DE (1) DE69528838T2 (hu)
DK (1) DK0777477T3 (hu)
ES (1) ES2187566T3 (hu)
HU (1) HU227759B1 (hu)
MX (1) MX9701390A (hu)
NO (1) NO322200B1 (hu)
NZ (1) NZ291223A (hu)
PL (1) PL181215B1 (hu)
PT (1) PT777477E (hu)
RU (1) RU2140782C1 (hu)
SK (1) SK282183B6 (hu)
TW (1) TW493984B (hu)
UA (1) UA42781C2 (hu)
WO (1) WO1996005834A1 (hu)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608073B1 (en) 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
JP2001253826A (ja) * 2000-03-09 2001-09-18 Maruzen Pharmaceut Co Ltd 内服用剤
US7183410B2 (en) 2001-08-02 2007-02-27 Bidachem S.P.A. Stable polymorph of flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
US20040253311A1 (en) * 2002-12-18 2004-12-16 Roger Berlin Multi-layer tablet comprising non-steroidal anti-inflammatory drugs, decongestants and non-sedating antihist amines
JP2009503020A (ja) 2005-08-03 2009-01-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 肥満症の治療におけるフリバンセリンの使用
WO2007048803A1 (en) 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
ZA200803566B (en) * 2005-12-12 2009-10-28 Adcock Ingram Ltd Pharmaceutical compositions
EP2037927B1 (en) 2006-06-30 2010-01-27 Boehringer Ingelheim International GmbH Flibanserin for the treatment of urinary incontinence and related diseases
EP2039359A4 (en) 2006-07-12 2009-11-25 Aska Pharm Co Ltd ANALGICAL AGENT
EA200900264A1 (ru) 2006-08-14 2009-08-28 Бёрингер Ингельхайм Интернациональ Гмбх Композиции флибансерина и способ их приготовления
EA200900270A1 (ru) 2006-08-25 2009-08-28 Бёрингер Ингельхайм Интернациональ Гмбх Системы регулируемого высвобождения и способ их приготовления
CN101516348B (zh) * 2006-10-05 2012-02-08 兴和株式会社 含有布洛芬和氨甲环酸的固形制剂
UY31335A1 (es) 2007-09-12 2009-04-30 Tratamiento de sintomas vasomotores
WO2009130342A1 (es) * 2008-04-23 2009-10-29 Farmasierra Manufacturing, S.L. Formulación farmacéutica mejorada a base de ibuprofeno y codeína
ES2365961B1 (es) 2010-03-30 2013-01-24 Farmasierra Manufacturing S.L. Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada.
KR101317809B1 (ko) * 2011-06-07 2013-10-16 한미약품 주식회사 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물
KR20140096571A (ko) 2013-01-28 2014-08-06 한미약품 주식회사 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법
CN107106502A (zh) 2014-08-28 2017-08-29 赛诺菲-安万特德国有限公司 用于治疗急性疼痛的薄膜包衣片
CN105395508B (zh) * 2015-12-14 2018-06-29 西南药业股份有限公司 一种洛芬待因复方制剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571400A (en) * 1984-12-18 1986-02-18 Belleview Pharmaceutical, Inc. Dihydrocodeine/ibuprofen pharmaceutical compositions and method
GB8905815D0 (en) * 1989-03-14 1989-04-26 Beecham Group Plc Medicament
GB9121204D0 (en) * 1991-10-04 1991-11-20 Euro Celtique Sa Medicament

Also Published As

Publication number Publication date
UA42781C2 (uk) 2001-11-15
KR970705389A (ko) 1997-10-09
CZ54697A3 (en) 1997-12-17
KR100397082B1 (ko) 2004-02-11
MX9701390A (es) 1998-06-30
PT777477E (pt) 2003-03-31
PL181215B1 (pl) 2001-06-29
PL318807A1 (en) 1997-07-07
NO970782D0 (no) 1997-02-20
CN1159754A (zh) 1997-09-17
CN1083265C (zh) 2002-04-24
EP0777477B1 (en) 2002-11-13
NO970782L (no) 1997-02-20
TW493984B (en) 2002-07-11
WO1996005834A1 (en) 1996-02-29
EP0777477A1 (en) 1997-06-11
SK282183B6 (sk) 2001-11-06
DK0777477T3 (da) 2003-03-17
CA2156768A1 (en) 1996-02-24
DE69528838T2 (de) 2003-07-10
DE69528838D1 (de) 2002-12-19
JP3874793B2 (ja) 2007-01-31
ES2187566T3 (es) 2003-06-16
SK23697A3 (en) 1997-08-06
HU227759B1 (en) 2012-02-28
NZ291223A (en) 1998-12-23
RU2140782C1 (ru) 1999-11-10
AU3228995A (en) 1996-03-14
ATE227574T1 (de) 2002-11-15
JPH10504557A (ja) 1998-05-06
CZ287558B6 (en) 2000-12-13
BG63329B1 (bg) 2001-10-31
AU699224B2 (en) 1998-11-26
BR9508760A (pt) 1998-01-13
NO322200B1 (no) 2006-08-28
BG101252A (en) 1998-02-27

Similar Documents

Publication Publication Date Title
HUT77385A (hu) Ibuprofent és kodeint tartalmazó, tökéletesített gyógyászati készítmények
MY112915A (en) Multiple unit tableted dosage form 1
IL127244A0 (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
PL337126A1 (en) Novel compounds
AU3632497A (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
NZ328898A (en) Sustained release formulation containing collagen and glycosaminoglycan additives
BG104727A (en) Pharmaceutical composition of topiramate
EP0744942A4 (en) HYDROGEL FORMULATION WITH CONTROLLED RELEASE
GEP20002013B (en) Therapeutical Means
EP1025845A3 (en) Hydromorphone tablets
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
MX9704037A (es) 1,1-dioxidos de 1,2,5-tiadiazolidin-3-ona 2-substituida y composiciones y metodo de uso de los mismos.
MY113908A (en) Rapidly disintegrating formulation comprising tramadol or a tramadol salt
MX9708394A (es) Composicion farmaceutica que contiene clorhidrato de tiagabina y el proceso para su preparacion.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
EP1169058A4 (en) INSULIN-LIKE GROWTH FACTOR AND BINDING PROTEIN PROTEIN 4
IL110011A0 (en) Pharmaceutical compositions for the treatment of schizophrenia
MY118175A (en) Crystalline pharmaceutical product
UA42749C2 (uk) N,n-діетил-8,8-дипропіл-2-азаспіро[4,5]декан-2-пропанамін дималеат, фармацевтична композиція, спосіб лікування
WO2001021178A3 (en) Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs
JO1880B1 (en) Format 1 for multi-unit calibration discs
WO2003014328A3 (en) Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
PL299147A1 (en) Pharmaceutical agent for treating central nerve system disorders